Search Results - "Siberil, Sophie"

Refine Results
  1. 1
  2. 2

    Autophagy Modulation by Viral Infections Influences Tumor Development by Leonardi, Lucas, Sibéril, Sophie, Alifano, Marco, Cremer, Isabelle, Joubert, Pierre-Emmanuel

    Published in Frontiers in oncology (22-10-2021)
    “…Autophagy is a self-degradative process important for balancing cellular homeostasis at critical times in development and/or in response to nutrient stress…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP by Gérart, Stéphane, Sibéril, Sophie, Martin, Emmanuel, Lenoir, Christelle, Aguilar, Claire, Picard, Capucine, Lantz, Olivier, Fischer, Alain, Latour, Sylvain

    Published in Blood (24-01-2013)
    “…Invariant natural killer (iNKT) T cells and mucosal-associated invariant T (MAIT) cells represent peculiar T-lymphocyte subpopulations with innate-like…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effective control of Staphylococcus aureus lung infection despite tertiary lymphoid structure disorganisation by Regard, Lucile, Martin, Clémence, Teillaud, Jean-Luc, Lafoeste, Hélène, Vicaire, Hugues, Ladjemi, Maha Zohra, Ollame-Omvane, Emilie, Sibéril, Sophie, Burgel, Pierre-Régis

    Published in The European respiratory journal (01-04-2021)
    “…Tertiary lymphoid structures (TLS) are triggered by persistent bronchopulmonary infection with , but their roles remain elusive. The present study sought to…”
    Get full text
    Journal Article
  7. 7

    Autophagy modulation by viruses: An important role in tumor progression by Leonardi, Lucas, Sibéril, Sophie, Alifano, Marco, Cremer, Isabelle, Joubert, Pierre-Emmanuel

    Published in M.S. Médecine sciences (18-02-2022)
    “…Autophagy is an important process for cellular homeostasis at critical steps of development or in response to environmental stress. In the context of cancers,…”
    Get more information
    Journal Article
  8. 8

    Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer Therapy by Riller, Quentin, Varthaman, Aditi, Sibéril, Sophie

    “…Therapeutic monoclonal antibodies (mAb) have changed the landscape of cancer therapy. With advances in the understanding of tumour biology and its…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus? by Deligne, Claire, Milcent, Benoît, Josseaume, Nathalie, Teillaud, Jean-Luc, Sibéril, Sophie

    Published in Frontiers in immunology (14-08-2017)
    “…Clinical responses to anti-tumor monoclonal antibody (mAb) treatment have been regarded for many years only as a consequence of the ability of mAbs to destroy…”
    Get full text
    Journal Article
  11. 11

    Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases by SIBÉRIL, SOPHIE, ELLURU, SRIRAMULU, GRAFF-DUBOIS, STÉPHANIE, NEGI, VIR-SINGH, DELIGNAT, SANDRINE, MOUTHON, LUC, LACROIX-DESMAZES, SÉBASTIEN, KAZATCHKINE, MICHEL D., BAYARY, JAGADEESH, KAVERI, SRINI V.

    Published in Annals of the New York Academy of Sciences (01-09-2007)
    “…:  Initially used for the treatment of immunodeficiencies, intravenous immunoglobulins (IVIg) have increasingly been used as immunomodulatory agents in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Intravenous immunoglobulin: an update on the clinical use and mechanisms of action by Negi, Vir-Singh, Elluru, Sriramulu, Sibéril, Sophie, Graff-Dubois, Stéphanie, Mouthon, Luc, Kazatchkine, Michel D, Lacroix-Desmazes, Sébastien, Bayry, Jagadeesh, Kaveri, Srini V

    Published in Journal of Clinical Immunology (01-05-2007)
    “…Initially used as a replacement therapy for immunodeficiency diseases, intravenous immunoglobulin (IVIg) is now widely used for a number of autoimmune and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    FcγR: The key to optimize therapeutic antibodies? by Sibéril, Sophie, Dutertre, Charles-Antoine, Fridman, Wolf-Herman, Teillaud, Jean-Luc

    Published in Critical reviews in oncology/hematology (01-04-2007)
    “…Abstract The binding of IgG to receptors for the Fc region of IgG (FcγR) is a critical step for the initiation and the control of effector immune functions…”
    Get full text
    Journal Article
  17. 17

    Isolation and characterization of anti-FcγRIII (CD16) llama single-domain antibodies that activate natural killer cells by Behar, Ghislaine, Sibéril, Sophie, Groulet, Agnès, Chames, Patrick, Pugnière, Martine, Boix, Charlotte, Sautès-Fridman, Catherine, Teillaud, Jean-Luc, Baty, Daniel

    Published in Protein engineering, design and selection (01-01-2008)
    “…FcγRIII (CD16) plays an important role in the anti-tumor effects of therapeutic antibodies. Bi-specific antibodies (bsAbs) targeting FcγRIII represent a…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected Lungs by Teillaud, Jean-Luc, Regard, Lucile, Martin, Clémence, Sibéril, Sophie, Burgel, Pierre-Régis

    “…Animal models can be helpful tools for deciphering the generation, maintenance, and role of tertiary lymphoid structures (TLS) during infections or tumor…”
    Get more information
    Journal Article
  20. 20

    CD20 peptides elicit a protective anti-tumor immune response in vivo (VAC5P.1126) by TEILLAUD, JEAN-LUC, Riller, Quentin, Siberil, Sophie

    Published in The Journal of immunology (1950) (01-05-2015)
    “…Abstract We have investigated whether human CD20 (huCD20)-derived peptides are able to elicit a protective anti-tumor immune response in vivo. Based on in…”
    Get full text
    Journal Article